• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Vanda Pharmaceuticals Inc. - Common Stock (NQ:VNDA)

8.820 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Dec 31, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 13,864
Open 8.820
Bid (Size) 8.830 (200)
Ask (Size) 8.900 (500)
Prev. Close 8.820
Today's Range 8.820 - 8.820
52wk Range 3.809 - 9.600
Shares Outstanding 55,638,166
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
What's Going On With Vanda Pharmaceuticals Stock Wednesday? ↗
December 31, 2025
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) shares are trading higher Wednesday after the company announced it received FDA approval of NEREUS for the prevention of vomiting induced by motion. 
Via Benzinga
Here are the top movers in Wednesday's session. ↗
December 31, 2025
Via Chartmill

Performance

YTD
N/A
N/A
1 Month
+79.3%
+79.3%
3 Month
+70.9%
+70.9%
6 Month
+77.5%
+77.5%
1 Year
+83.0%
+83.0%

More News

Read More
Top movers analysis in the middle of the day on 2025-12-31: top gainers and losers in today's session. ↗
December 31, 2025
Via Chartmill
The market is filled with gapping stocks in Wednesday's session. ↗
December 31, 2025
Via Chartmill
VNDA Stock On Track To Open At Three-Year High – FDA Clears First New Motion Sickness Drug In Decades ↗
December 31, 2025
Via Stocktwits
Vanda’s FDA Moment: A High-Stakes Bet That Could Redefine The Stock ↗
December 29, 2025
Via Stocktwits
The Christmas Party Is Still Ongoing In These Stocks: Nvidia, Sidus Space, Coupang, Vanda Pharmaceuticals, ImmuCell ↗
December 26, 2025
Via Stocktwits
Get insights into the top gainers and losers of Wednesday's pre-market session. ↗
December 31, 2025
Via Chartmill
News headline image
Nasdaq, S&P 500 Futures Edge Lower For Final Session Of 2025: Why NVDA, TSLA, VNDA Are On Traders' Radar Today ↗
December 31, 2025
Via Stocktwits
Topics Artificial Intelligence ETFs Economy
News headline image
Biopharma’s Year-End Rollercoaster: Mereo Plummets 90% as BioMarin Seals $4.8 Billion Amicus Deal
December 29, 2025
Via MarketMinute
Topics ETFs Intellectual Property
Vanda Pharmaceuticals Says FDA Will Take More Time To Decide On Tradipitant Clinical Hold Re-Review ↗
November 28, 2025
Via Stocktwits
News headline image
Earnings Scheduled For October 29, 2025 ↗
October 29, 2025
Via Benzinga
News headline image
This Smallcap Pharma Stock Is Gaining Retail Buzz Ahead Of A Key FDA Ruling ↗
December 26, 2025
Via Stocktwits
News headline image
Curious about the stocks that are showing activity after the closing bell on Thursday? ↗
December 04, 2025
Via Chartmill
News headline image
Should You Invest in This Under-the-Radar Weight Loss Stock? ↗
November 30, 2025
Via The Motley Fool
News headline image
Vanda Reports Big Win In Wegovy Support Study, Analysts Upbeat ↗
November 20, 2025
Via Benzinga
News headline image
Which stocks are moving on Tuesday? ↗
November 18, 2025
Via Chartmill
News headline image
Top movers in Tuesday's session ↗
November 18, 2025
Via Chartmill
News headline image
Side Effects From Wegovy? This Vanda Pharmaceuticals' Drug Halves Vomiting In Patients ↗
November 18, 2025
Via Benzinga
News headline image
Let's uncover which stocks are experiencing notable gaps during today's session. ↗
November 18, 2025
Via Chartmill
News headline image
This Docebo Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Wednesday ↗
November 05, 2025
Via Benzinga
News headline image
This Trex Company Analyst Turns Bearish; Here Are Top 5 Downgrades For Wednesday ↗
November 05, 2025
Via Benzinga
News headline image
VANDA PHARMACEUTICALS INC (NASDAQ:VNDA) Reports Q3 2025 Earnings Miss on Revenue, Beat on EPS ↗
October 29, 2025
Via Chartmill
Topics Earnings
News headline image
Jim Cramer Calls Cameco A Good Company, Recommends Buying This Financial Stock ↗
October 27, 2025
Via Benzinga
News headline image
AnaptysBio Charts Path To Split Into Two Public Companies By 2026 ↗
September 30, 2025
Via Benzinga

Frequently Asked Questions

Is Vanda Pharmaceuticals Inc. - Common Stock publicly traded?
Yes, Vanda Pharmaceuticals Inc. - Common Stock is publicly traded.
What exchange does Vanda Pharmaceuticals Inc. - Common Stock trade on?
Vanda Pharmaceuticals Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Vanda Pharmaceuticals Inc. - Common Stock?
The ticker symbol for Vanda Pharmaceuticals Inc. - Common Stock is VNDA on the Nasdaq Stock Market
What is the current price of Vanda Pharmaceuticals Inc. - Common Stock?
The current price of Vanda Pharmaceuticals Inc. - Common Stock is 8.820
When was Vanda Pharmaceuticals Inc. - Common Stock last traded?
The last trade of Vanda Pharmaceuticals Inc. - Common Stock was at 12/31/25 04:00 PM ET
What is the market capitalization of Vanda Pharmaceuticals Inc. - Common Stock?
The market capitalization of Vanda Pharmaceuticals Inc. - Common Stock is 490.73M
How many shares of Vanda Pharmaceuticals Inc. - Common Stock are outstanding?
Vanda Pharmaceuticals Inc. - Common Stock has 491M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap